Pharmacological inhibition of GPX4 with RSL3 or blockade of system xCT with erastin markedly sensitizes NPC cells to ferroptotic death, underscoring the therapeutic relevance of this pathway [26,44,45]. This evidence concerns the gene GPX4 and nasopharyngeal carcinoma.